Author Archives: Mayer Winkler

Unhealthy Person

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

When traders look at a stock at its highs and imagine what would be had they gotten in at the lows, the thought that invariably gets triggered is “At the ...
Read Full Story »
Lithium-ion battery

2 Companies Set to Benefit From the Lithium Boom

The electric vehicle (EV) space is set to become one of the fastest growing markets of the next 50 years. This revolution is, concurrently, driving a revolution in another space ...
Read Full Story »
analysis

Sanofi Just Can’t Catch a Break, Knocking at Major Support Again

Investor sentiment surrounding French pharma giant Sanofi S.A. (NYSE: SNY) continues to sour after a string of disappointing news in recent months has brought its shares down below the key ...
Read Full Story »
Beer Taps

2 Craft Beer Stocks to Consider in the Wake of the Anheuser-Busch, SABMiller Deal

The U.S. Department of Justice just announced that it was happy with the proposed acquisition by Anheuser-Busch InBev S.A./N.V. (NYSE: BUD) of SABMiller. As per a predetermined condition of the agreement, ...
Read Full Story »
Suburbia

3 Stocks Set to Benefit From Existing Home Sales Data

Existing home sales data out of the United States last week revealed the strongest growth rate since the beginning of 2007. The data showed a 1.1% increase between May and ...
Read Full Story »
snow tires

3 Stocks Unexpectedly Benefiting From Low Gas Prices

Conventional analysis and opinion suggested that the reduction in average gas prices in the United States between 2014 and 2015 resulted in an increase in savings and a concurrent reduction ...
Read Full Story »
Shanghai

3 Stocks to Watch as China Stabilizes

China just surprised the markets by reporting an unexpected rise in capital inflows. Foreign exchange reserves have risen by the most in 14 months on the back of a falling ...
Read Full Story »
Handshake

3 Stocks Set to Benefit From a Tighter Jobs Market

Employment data out of the United States came out better than expected this week, with nonfarm payrolls due shortly. The Challenger Job-Cut Report is still below average, and Moody's ADP private ...
Read Full Story »
Losing sports fan

How To Get An Exposure to Private Daily Fantasy Sports Leaders

New York lawmakers just voted to pass a bill that will see a young subsector of the fantasy sports space become regulated under state law. That is, daily fantasy sports, ...
Read Full Story »
Elon Musk

3 Clean Energy Stocks To Consider While Markets Watch Musk

With Elon Musk and Tesla Motors Inc (NASDAQ:TSLA) attempted takeover of SolarCity Corp (NASDAQ:SCTY) dominating energy headlines, the renewable sector is drawing a considerable amount of speculative and long term ...
Read Full Story »
PRINCE CHARLES REACTS TO BAD WEATHER IN SCOTLAND

Three Less Obvious Opportunities In Response To Brexit

43 years since joining the European Community in 1973, what would later become the European Union, the voters in the United Kingdom have finally voted to leave. Plenty has been ...
Read Full Story »
VR

A Quick Look of E3 and the Gaming Stocks Involved

The Electronic Entertainment Expo, or E3, just wrapped up in Los Angeles, and a number of companies took the opportunity to reveal their latest offerings in the gaming and entertainment ...
Read Full Story »
laptop PC

Net Neutrality Winners and Losers

This week, the U.S. Court of Appeals for the D.C. Circuit upheld a ruling that supports net neutrality. The concept refers to the distribution of content by telecom providers, and ...
Read Full Story »
copper pipes

2 Very Different Stocks Set to Benefit From a Commodities Boom

Commodities look like they are about to end their half-decade slump, which may kick off a bull run that could last into the next decade. The Bloomberg commodities index is set ...
Read Full Story »
Female patient on gurney

3 Biotechs That Just Announced Successful Phase 2 Trials

If the ongoing drama and wild stock movements with Sarepta Therapeutics (NASDAQ: SRPT) and its back and forth with the U.S. Food and Drug Administration (FDA) has proven one thing, ...
Read Full Story »